Advertisement
U.S. markets close in 2 hours 22 minutes
  • S&P 500

    5,250.62
    +2.13 (+0.04%)
     
  • Dow 30

    39,760.18
    +0.10 (+0.00%)
     
  • Nasdaq

    16,376.78
    -22.75 (-0.14%)
     
  • Russell 2000

    2,124.73
    +10.38 (+0.49%)
     
  • Crude Oil

    82.77
    +1.42 (+1.75%)
     
  • Gold

    2,239.20
    +26.50 (+1.20%)
     
  • Silver

    24.92
    +0.17 (+0.70%)
     
  • EUR/USD

    1.0800
    -0.0029 (-0.27%)
     
  • 10-Yr Bond

    4.2020
    +0.0060 (+0.14%)
     
  • GBP/USD

    1.2627
    -0.0011 (-0.09%)
     
  • USD/JPY

    151.3520
    +0.1060 (+0.07%)
     
  • Bitcoin USD

    70,716.34
    +1,624.59 (+2.35%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Leonovus Announces Closing of $3.44 Million Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

OTTAWA, May 06, 2021 (GLOBE NEWSWIRE) -- Leonovus Inc. (TSXV:LTV) (the “Company” or “Leonovus”), is pleased to announce the closing of its marketed short form prospectus offering pursuant to which the Company issued 6,143,572 units of the Company (the “Units”) at a price of $0.56 per Unit for gross proceeds of $3,440,400.32 (the “Offering”). The Offering was led by Research Capital Corporation as lead agent and sole bookrunner (the “Lead Agent”), on behalf of a syndicate of agents, including Canaccord Genuity Corp. (collectively with the Lead Agent, the “Agents”).

Each Unit is be comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant of the Company (a “Warrant”). Each Warrant is exercisable into one Common Share (a “Warrant Share”) at a price of $0.70 for a period of 36 months following completion of the Offering.

The Company has granted the Agents an option (the “Over-Allotment Option”) to cover over-allotments and for market stabilization purposes, exercisable in whole or in part at the sole discretion of the Agents, at any time up to 30 days from the closing of the Offering, to increase the size of the Offering by up to 15% of the number of Units (and/or the components thereof) sold pursuant to the Offering, on the same terms and conditions of the Offering.

The net proceeds raised under the Offering will be used for product development and management, sales and marketing, operating expenses, and general and administrative expenses as well as for working capital requirements and other general corporate purposes.

The TSX Venture Exchange (“TSXV”) has conditionally accepted the listing of the Warrants. It is anticipated that the Warrants will commence trading on the TSXV under the symbol “LTV.WT” two business days following completion of all listing requirements of the TSXV, and issuance of the TSXV's bulletin confirming the date of listing.

The securities described in this press release have not been and will not be registered under the United States Securities Act of 1933, as amended (“U.S. Securities Act”) or any state securities laws. Accordingly, the securities may not be offered or sold in the United States (as such term is defined in Regulation S under the U.S. Securities Act) or to, or for the account or benefit of, a U.S. person (as such term is defined in Regulation S under the U.S. Securities Act) except pursuant to transactions exempt from registration under the U.S. Securities Act and under the securities laws of any applicable state. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities in the United States. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

About Leonovus

Leonovus is a secure data management software company. The Leonovus suite of data management tools offer an organization what it needs for a complete end-to-end data-centric solution. This solution can stand on its own, or it can easily integrate with the organization's zero-trust strategy and architecture. It takes seamless advantage of the organization's existing storage infrastructure and network architecture, working on-premises, in the cloud, or both. It extends the data-centric controls across the entire architecture, including cloud resources. And it supplies these cybersecurity capabilities for the full lifespan of the data and beyond.

The flexible and straightforward solution does not require changes in the method of data use. Applications, services, and users all interact with the data the same way they always have. The system ensures the right users get access to the correct data at the right time, but securely.

In addition to working with existing systems, the Leonovus solution aids in the organization's digital transformation by enabling ultramodern data concepts necessary for the data-driven world. These capabilities are included in an automated solution requiring little operations effort and no new skills or expertise needed.

The main elements of the Leonovus Unified Smart Data Management suite are:

Data Discovery - classification and understanding of your existing data sets.
Smart Filer - transparent file-based data controls for cost, flexibility, and scalability.
Vault - multi-cloud data management for data lifespan.
Data View Gateways - controlled repository internal/external data sharing.
Smart Secure Data Lake - a multi-sourced context-rich repository for advanced analytics.
Consolidata - multi-sourced data collation and aggregation for near real-time insights.
XVault – protocol independent, ultra-secure remote data sharing solution; coming soon.

Each is available independently or together as a comprehensive solution set. To learn more, please visit www.leonovus.com.

For More Information, please contact:
George Pretli
Chief Financial Officer
+1.613.319.3540
gpretli@leonovus.com

Caution regarding forward-looking information

This press release contains forward-looking statements and information, including statements relating to the expected use of proceeds and listing of the Warrants, which may involve risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Factors that might cause a difference include, but are not limited to, competitive developments, risks associated with Leonovus' growth, the state of the financial markets, regulatory risks and other factors. There can be no assurance or guarantees that any statements of forward-looking information contained in this release will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral statements containing forward-looking information are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. Unless otherwise required by applicable securities laws, Leonovus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers should not place undue reliance on any statements of forward-looking information that speak only as of the date of this release. Further information on Leonovus' public filings, including its most recent audited consolidated financial statements, are available at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Advertisement